182 related articles for article (PubMed ID: 23746523)
1. Conformational determinants for the recruitment of ERCC1 by XPA in the nucleotide excision repair (NER) Pathway: structure and dynamics of the XPA binding motif.
Fadda E
Biophys J; 2013 Jun; 104(11):2503-11. PubMed ID: 23746523
[TBL] [Abstract][Full Text] [Related]
2. The XPA-binding domain of ERCC1 is required for nucleotide excision repair but not other DNA repair pathways.
Orelli B; McClendon TB; Tsodikov OV; Ellenberger T; Niedernhofer LJ; Schärer OD
J Biol Chem; 2010 Feb; 285(6):3705-3712. PubMed ID: 19940136
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for the recruitment of ERCC1-XPF to nucleotide excision repair complexes by XPA.
Tsodikov OV; Ivanov D; Orelli B; Staresincic L; Shoshani I; Oberman R; Schärer OD; Wagner G; Ellenberger T
EMBO J; 2007 Nov; 26(22):4768-76. PubMed ID: 17948053
[TBL] [Abstract][Full Text] [Related]
4. DNA repair gets physical: mapping an XPA-binding site on ERCC1.
Croteau DL; Peng Y; Van Houten B
DNA Repair (Amst); 2008 May; 7(5):819-26. PubMed ID: 18343204
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the XPA and ssDNA-binding surfaces on the central domain of human ERCC1 reveals evidence for subfunctionalization.
Tripsianes K; Folkers GE; Zheng C; Das D; Grinstead JS; Kaptein R; Boelens R
Nucleic Acids Res; 2007; 35(17):5789-98. PubMed ID: 17720715
[TBL] [Abstract][Full Text] [Related]
6. New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy.
Gentile F; Tuszynski JA; Barakat KH
J Mol Graph Model; 2016 Apr; 65():71-82. PubMed ID: 26939044
[TBL] [Abstract][Full Text] [Related]
7. Small Molecule Antagonists of the DNA Repair ERCC1/XPA Protein-Protein Interaction.
Obermann R; Yemane B; Jarvis C; Franco FM; Kyriukha Y; Nolan W; Gohara B; Krezel AM; Wildman SA; Janetka JW
ChemMedChem; 2024 Apr; 19(8):e202300648. PubMed ID: 38300970
[TBL] [Abstract][Full Text] [Related]
8. Characterization of an inhibitory dynamic pharmacophore for the ERCC1-XPA interaction using a combined molecular dynamics and virtual screening approach.
Barakat KH; Torin Huzil J; Luchko T; Jordheim L; Dumontet C; Tuszynski J
J Mol Graph Model; 2009 Sep; 28(2):113-30. PubMed ID: 19473860
[TBL] [Abstract][Full Text] [Related]
9. The role of conformational selection in the molecular recognition of the wild type and mutants XPA67-80 peptides by ERCC1.
Fadda E
Proteins; 2015 Jul; 83(7):1341-51. PubMed ID: 25973722
[TBL] [Abstract][Full Text] [Related]
10. Mutations in XPA that prevent association with ERCC1 are defective in nucleotide excision repair.
Li L; Peterson CA; Lu X; Legerski RJ
Mol Cell Biol; 1995 Apr; 15(4):1993-8. PubMed ID: 7891694
[TBL] [Abstract][Full Text] [Related]
11. Sequential binding of DNA repair proteins RPA and ERCC1 to XPA in vitro.
Saijo M; Kuraoka I; Masutani C; Hanaoka F; Tanaka K
Nucleic Acids Res; 1996 Dec; 24(23):4719-24. PubMed ID: 8972858
[TBL] [Abstract][Full Text] [Related]
12. Functional and physical interactions between ERCC1 and MSH2 complexes for resistance to cis-diamminedichloroplatinum(II) in mammalian cells.
Lan L; Hayashi T; Rabeya RM; Nakajima S; Kanno Si; Takao M; Matsunaga T; Yoshino M; Ichikawa M; Riele Ht; Tsuchiya S; Tanaka K; Yasui A
DNA Repair (Amst); 2004 Feb; 3(2):135-43. PubMed ID: 14706347
[TBL] [Abstract][Full Text] [Related]
13. Virtual screening and biological evaluation of inhibitors targeting the XPA-ERCC1 interaction.
Barakat KH; Jordheim LP; Perez-Pineiro R; Wishart D; Dumontet C; Tuszynski JA
PLoS One; 2012; 7(12):e51329. PubMed ID: 23272099
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of nucleotide excision repair by anti-XPA monoclonal antibodies which interfere with binding to RPA, ERCC1, and TFIIH.
Saijo M; Matsuda T; Kuraoka I; Tanaka K
Biochem Biophys Res Commun; 2004 Sep; 321(4):815-22. PubMed ID: 15358100
[TBL] [Abstract][Full Text] [Related]
15. Multiple DNA binding domains mediate the function of the ERCC1-XPF protein in nucleotide excision repair.
Su Y; Orelli B; Madireddy A; Niedernhofer LJ; Schärer OD
J Biol Chem; 2012 Jun; 287(26):21846-55. PubMed ID: 22547097
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle checkpoint abrogator UCN-01 inhibits DNA repair: association with attenuation of the interaction of XPA and ERCC1 nucleotide excision repair proteins.
Jiang H; Yang LY
Cancer Res; 1999 Sep; 59(18):4529-34. PubMed ID: 10493501
[TBL] [Abstract][Full Text] [Related]
17. Human nucleotide excision repair protein XPA: NMR spectroscopic studies of an XPA fragment containing the ERCC1-binding region and the minimal DNA-binding domain (M59-F219).
Buchko GW; Isern NG; Spicer LD; Kennedy MA
Mutat Res; 2001 Jun; 486(1):1-10. PubMed ID: 11356331
[TBL] [Abstract][Full Text] [Related]
18. ERCC1, XPF and XPA-locoregional differences and prognostic value of DNA repair protein expression in patients with head and neck squamous cell carcinoma.
Prochnow S; Wilczak W; Bosch V; Clauditz TS; Muenscher A
Clin Oral Investig; 2019 Aug; 23(8):3319-3329. PubMed ID: 30498981
[TBL] [Abstract][Full Text] [Related]
19. Metal binding mediated conformational change of XPA protein:a potential cytotoxic mechanism of nickel in the nucleotide excision repair.
Hu J; Hu Z; Zhang Y; Gou X; Mu Y; Wang L; Xie XQ
J Mol Model; 2016 Jul; 22(7):156. PubMed ID: 27307058
[TBL] [Abstract][Full Text] [Related]
20. Nucleotide excision repair is associated with the replisome and its efficiency depends on a direct interaction between XPA and PCNA.
Gilljam KM; Müller R; Liabakk NB; Otterlei M
PLoS One; 2012; 7(11):e49199. PubMed ID: 23152873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]